Skip to main content
Menu
US

Resource Center

Filters
Select resource types
Select products & services
Select solutions
13 - 24 of 1630 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Other Icon   Other
Software as a Service Agreement (EVOYA Platform)
EVOYA Platform SaaS terms and conditions.
Application Note Icon   Application Note
HTRF phospho-total lysis buffer: a universal alternative to RIPA lysis buffers
This application note compares the use of Revvity’s HTRF phospho-total lysis buffer with commonly-used RIPA lysis buffers for the analysis of cell signaling pathways in different types of samples.
Publication Icon   Literature - Publication Review
Fibrosis study investigating the role of GPCR signaling in fibrosis development
Discover publications on GPCR signaling pathways involved in fibrotic disorders.
Application Note Icon   Application Note
A simple, reliable, no-wash assay platform for AAV capsid titer quantification based on HTRF technology
In this application note you will discover a reliable and efficient method for quantifying AAV titers for AAV1, AAV2, AAV3B, AAV5, AAV6, AAV8, and AAV9 serotypes.
Infographic Icon   Infographic
Disruptive innovation in protein degradation technologies
Discover this original infographic for in-depth insight about new protein degradation technologies including PROTAC, ATTEC, LYTAC, AUTAC.
Publication Icon   Literature - Publication Review
HTRF solutions for cytokines in autoimmune inflammation research
Discover publications using cytokine read-outs to screen drug targets in autoimmune diseases.
Technical Note Icon   Technical Note
Guidelines from PBMC isolation to cytokine assay optimization
This tech note will provide you with a complete step by step methodology to purify PBMCs and use them in cytokine quantification assays with HTRF
Application Note Icon   Application Note
Inhibition of FGFR signaling pathways studied in cancer cell lines using HTRF
In this application note, we show that a pan-FGFR inhibitor, AZD4547, used in different clinical phases depending on the cancer type, is able to inhibit or even suppress the abnormal phosphorylation of FGFRs and their key effectors in 3 different types of cancer cell lines: KG-1 (blood cancer), SNU-16 (gastric cancer), and KMS-11 (multiple myeloma).
Guide Icon   Guide
Get your insulin guide
This brochure describes the functionality and benefits of all 3 assay kits available for insulin quantification.
Publication Icon   Literature - Publication Review
GPCR signaling in cardiovascular research addressed with HTRF second messenger assays
This note compiles published examples of cardiovascular related studies in which cAMP and IP-One HTRF second messengers assays were successfully used to monitor Gi/s and Gq activity and allowed for a better understanding or addressing of CVDs.
Application Note Icon   Application Note
HTRF assays handle low- to high affinity protein-protein interactions
This application note demonstrated that HTRF PPI reagents are successfully used combining high detection performance, accurate modulators screening, and pharmacological characterization.
Publication Icon   Literature - Publication Review
Tau aggregation in Alzheimer's disease pathogenesis addressed with HTRF assays
Literature review investigating mechanisms of the development of Alzheimer’s disease, tauopathies, and drug discovery efforts.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.